ICAD Icad Inc

icad Inc is a provider of image analysis, work flow solutions and radiation therapy for early identification and treatment of cancer. The company has cancer detection and cancer therapy segments.

As of 12/02/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  USA
IPO date:  08/03/2001
Outstanding shares:  25,333,935
Average volume:  379,270
Market cap:   $43,574,368
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B83YYY6
Valuation   (See tab for details)
PE ratio:   -3.47
PB ratio:   1.04
PS ratio:   1.34
Return on equity:   -30.05%
Net income %:   -40.43%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy